Stay updated on Pembrolizumab Post-Surgery in MSI-H Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Post-Surgery in MSI-H Solid Tumors Clinical Trial page.

Latest updates to the Pembrolizumab Post-Surgery in MSI-H Solid Tumors Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe page now shows a new revision tag (v3.6.4) replacing the previous v3.6.3. This indicates a minor maintenance update to the page rather than changes to the study details.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page footer now displays Revision: v3.6.3, replacing v3.6.2, indicating a version update to the page template. No substantive study content appears to be changed.SummaryDifference0.1%

- Check36 days agoChange DetectedThe page revision was updated from v3.6.0 to v3.6.2, signaling an internal update to the page framework. The visible study details remain unchanged.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page adds a recruitment status note ('No longer looking for participants') and new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study), improving user guidance and signaling current recruitment status. It also updates the 'Intervention / Treatment' heading to 'Intervention/Treatment' and changes the revision label from v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check58 days agoChange DetectedRevision tag updated from v3.5.4 to v3.5.5, indicating a minor page version update. It reflects a small update to the page's metadata rather than any changes to study content or results.SummaryDifference0.1%

- Check80 days agoChange DetectedThe footer now displays the updated frontend revision (v3.5.4), replacing the prior revision (v3.5.3), indicating a frontend version update.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab Post-Surgery in MSI-H Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Post-Surgery in MSI-H Solid Tumors Clinical Trial page.